
Stargardt disease (STGD1) represents one of the major common causes of inherited irreversible visual loss. Due to its high phenotypic and genotypic heterogeneity, STGD1 is a complex disease to understand. Non-invasive imaging, biochemical, and genetic advances have led to substantial improvements in unveiling the disease processes and novel promising therapeutic landscapes have been proposed. This review recapitulates the modalities for monitoring patients with STGD1 and the therapeutic options currently under investigation for the different stages of the disease.
optical coherence tomography, multimodal imaging, Review, RE1-994, gene therapy, inherited retinal dystrophy, Ophthalmology, Gene therapy; Inherited retinal dystrophy; Multimodal imaging; Optical coherence tomography; Stargardt disease, Clinical Optometry, stargardt disease
optical coherence tomography, multimodal imaging, Review, RE1-994, gene therapy, inherited retinal dystrophy, Ophthalmology, Gene therapy; Inherited retinal dystrophy; Multimodal imaging; Optical coherence tomography; Stargardt disease, Clinical Optometry, stargardt disease
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 18 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
